![infosurhoy](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/149/normal/Screenshot_2019-07-31_at_12.42.17.png?1564573365)
PPI use is negative prognostic marker in urothelial cancer.
infosurhoy,
—For patients with advanced urothelial cancer treated with atezolizumab, proton pump inhibitor (PPI) use is a negative…
—For patients with advanced urothelial cancer treated with atezolizumab, proton pump inhibitor (PPI) use is a negative…
(HealthDay News) — For patients with advanced urothelial cancer treated with atezolizumab, proton pump inhibitor (PPI) use is a…
Bottom Line: Proton pump inhibitor (PPI) use was associated with worse outcomes in patients with urothelial cancer treated with…
Bottom Line: Proton pump inhibitor (PPI) use was associated with worse outcomes in patients with urothelial cancer treated with…